AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&D
November 03, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 03, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has published a...
AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications
October 26, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company has...
AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals
September 19, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
RAFA to Distribute Axim’s Award-Winning Cannabinoid Chewing Gum CanChew®NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), an innovative biotechnology company...
AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans and Legacy Customers
July 11, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, July 11, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech), a world leader in hemp cannabinoid research and development, launched the Company’s community outreach and...
AXIM Biotechnologies Expands Executive Team and Advisory Board With Finance and Pro Sports Leaders: Seth Yakatan and Marvin Washington
January 28, 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 28, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) is proud to announce the following finance and community outreach-focused additions to the Company’s advisory...
AXIM Biotechnologies Featured in Marijuana Documentary “Cannabis is Medicine”
January 13, 2016 09:15 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) is pleased to announce that the Company’s efforts on clinical development of a patented cannabinoid-based medical...
Medical Marijuana, Inc. Investment – AXIM Biotech – Featured by Reuters; Cannabis "Gum to Treat Multiple Sclerosis" Pain and Spasticity
January 06, 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM® Biotechnologies,...
AXIM Featured by Reuters: Biotech Receives Cannabis Strains at “Discount for Gum to Treat Multiple Sclerosis”
January 05, 2016 13:39 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- A groundbreaking story by Reuters global news agency profiled AXIM® Biotechnologies, Inc. (OTC:AXIM) and the company’s upcoming clinical trials on the...
AXIM Biotechnologies Secures Land Down Payment for Hemp Life Sciences Manufacturing Site
October 30, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Oct. 30, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce that it has secured the down payment on land to build the Company’s manufacturing...
Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace to Advisory Board
August 26, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...